Unedited news and product information from vendors.
Clinical Ink Unveils New Web Site, Version 1.0 of its eSource Solution for Electronic Data Capture
Jan 15, 2008 (10:01 AM EST)
WINSTON SALEM, N.C., Jan. 15 /PRNewswire/ -- Clinical Ink, provider of the first true eSource solution for clinical trials, today announced the launch of its new Web site, and plans to release version 1.0 of its eSource solution in June 2008. The Web site, www.clinicalink.com , provides detailed explanations of Clinical Ink's solution for capturing and storing data during clinical trials. Clinical Ink provides customers with tablet PCs running proprietary software. The software allows data entry on customized documents that retain the look and feel of traditional paper data collection forms.
"Our system eliminates multiple data entry, increases accuracy and ultimately saves money by reducing the time to market," said Doug Pierce, CEO of Clinical Ink. "It also allows customers to manage, view and store the data and forms on our secure Web portal."
To create this breakthrough technology, Clinical Ink entered into an exclusive, worldwide license with Datasci, owner of a patent regarding the collection and validation of clinical trial data over the Internet. With this license, Clinical Ink was able to move forward and develop its unique solution.
"Datasci provided us with the protection we needed to enter the EDC market," said Pierce. "When we acquired the license from Datasci, we were acquiring a partner. Datasci has subsequently invested in Clinical Ink and they are an integral part of our success."
To date, Datasci has granted six non-exclusive patent licenses in the EDC marketplace.
"We are always thrilled to see one of our licensees succeeding in the market place," said Marc Kozam, co-founder of Datasci. "One of our fundamental goals is to help companies succeed."
About Clinical Ink
Clinical Ink was launched in 2006 to provide eSource solutions for clinical trials, eliminating the problems inherent to paper-based data collection and reducing the costs and time to market for pharmaceutical and medical device companies. By enhancing traditional EDC systems, Clinical Ink extends EDC to the source documents -- providing the first true eSource solution in the clinical trials market. Clinical Ink was founded by Thomas Littlejohn, III, M.D., President, Medical Director and co-owner of Piedmont Medical Research Group (PMG) and Doug Pierce, President and co-owner of Piermed, Inc. Visit us at www.clinicalink.com .
Contact: Leanne Jernigan Phone: (202) 973-1344 Email: email@example.com
CONTACT: Leanne Jernigan, +1-202-973-1344, firstname.lastname@example.org, forClinical Ink
Web site: http://www.clinicalink.com/